Adaptive Biotechnologies CorpNASDAQ:ADPT
- LAST PRICE4.3700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.2900/ 5
- Ask / Lots4.5100/ 1
- Open / Previous Close--- / 4.3700
- Day Range---
- 52 Week Range
- Volume170
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ADPT |
|---|---|---|
| 09:32 ET | 24412 | 4.45 |
| 09:33 ET | 1800 | 4.43 |
| 09:35 ET | 11566 | 4.4 |
| 09:37 ET | 1436 | 4.37 |
| 09:39 ET | 380 | 4.38 |
| 09:42 ET | 3954 | 4.3502 |
| 09:44 ET | 3692 | 4.33 |
| 09:46 ET | 10267 | 4.29 |
| 09:48 ET | 2600 | 4.31 |
| 09:50 ET | 871 | 4.325 |
| 09:51 ET | 6745 | 4.4 |
| 09:53 ET | 1717 | 4.37 |
| 09:55 ET | 2434 | 4.355 |
| 09:57 ET | 2403 | 4.355 |
| 10:00 ET | 510 | 4.341779 |
| 10:02 ET | 2135 | 4.31 |
| 10:04 ET | 2300 | 4.335 |
| 10:06 ET | 1852 | 4.33 |
| 10:08 ET | 4043 | 4.3275 |
| 10:09 ET | 4371 | 4.32 |
| 10:11 ET | 3438 | 4.34 |
| 10:13 ET | 2700 | 4.36 |
| 10:15 ET | 3633 | 4.395 |
| 10:18 ET | 1192 | 4.385 |
| 10:20 ET | 3650 | 4.43 |
| 10:22 ET | 3176 | 4.44 |
| 10:24 ET | 2358 | 4.43 |
| 10:26 ET | 3500 | 4.405 |
| 10:27 ET | 2347 | 4.4 |
| 10:29 ET | 1768 | 4.3988 |
| 10:31 ET | 2914 | 4.365 |
| 10:33 ET | 4322 | 4.375 |
| 10:36 ET | 2190 | 4.39 |
| 10:38 ET | 1525 | 4.39 |
| 10:40 ET | 2511 | 4.365 |
| 10:42 ET | 1141 | 4.3588 |
| 10:44 ET | 4441 | 4.375 |
| 10:45 ET | 800 | 4.38 |
| 10:47 ET | 6000 | 4.42 |
| 10:49 ET | 4312 | 4.42 |
| 10:51 ET | 5172 | 4.42 |
| 10:54 ET | 4805 | 4.42 |
| 10:56 ET | 1525 | 4.42 |
| 10:58 ET | 2856 | 4.425 |
| 11:00 ET | 4104 | 4.415 |
| 11:02 ET | 3778 | 4.4 |
| 11:03 ET | 2097 | 4.385 |
| 11:05 ET | 2226 | 4.37 |
| 11:07 ET | 2542 | 4.345 |
| 11:09 ET | 6255 | 4.345 |
| 11:12 ET | 11870 | 4.345 |
| 11:14 ET | 18466 | 4.32 |
| 11:16 ET | 4577 | 4.32 |
| 11:18 ET | 8201 | 4.34 |
| 11:20 ET | 2100 | 4.335 |
| 11:21 ET | 3708 | 4.335 |
| 11:23 ET | 2008 | 4.325 |
| 11:25 ET | 2628 | 4.33 |
| 11:27 ET | 2120 | 4.335 |
| 11:30 ET | 1599 | 4.345 |
| 11:32 ET | 18535 | 4.324 |
| 11:34 ET | 11815 | 4.33 |
| 11:36 ET | 2917 | 4.34 |
| 11:38 ET | 2582 | 4.315 |
| 11:39 ET | 700 | 4.315 |
| 11:41 ET | 1625 | 4.32 |
| 11:43 ET | 1845 | 4.305 |
| 11:45 ET | 1127 | 4.3098 |
| 11:48 ET | 2121 | 4.29 |
| 11:50 ET | 1373 | 4.295 |
| 11:52 ET | 974 | 4.295 |
| 11:54 ET | 1232 | 4.295 |
| 11:56 ET | 1154 | 4.295 |
| 11:57 ET | 5762 | 4.285 |
| 11:59 ET | 5136 | 4.29 |
| 12:01 ET | 6854 | 4.285 |
| 12:03 ET | 626 | 4.285 |
| 12:06 ET | 2520 | 4.285 |
| 12:08 ET | 1283 | 4.285 |
| 12:10 ET | 6032 | 4.305 |
| 12:12 ET | 680 | 4.3 |
| 12:14 ET | 5698 | 4.295 |
| 12:15 ET | 4788 | 4.28 |
| 12:17 ET | 1702 | 4.275 |
| 12:19 ET | 2783 | 4.2875 |
| 12:21 ET | 18005 | 4.315 |
| 12:24 ET | 793 | 4.315 |
| 12:26 ET | 20711 | 4.335 |
| 12:28 ET | 1641 | 4.335 |
| 12:30 ET | 4199 | 4.355 |
| 12:32 ET | 2025 | 4.385 |
| 12:33 ET | 2062 | 4.395 |
| 12:35 ET | 2850 | 4.4 |
| 12:37 ET | 1425 | 4.395 |
| 12:39 ET | 21274 | 4.45 |
| 12:42 ET | 5714 | 4.45 |
| 12:44 ET | 3639 | 4.455 |
| 12:46 ET | 16731 | 4.465 |
| 12:48 ET | 21851 | 4.44 |
| 12:50 ET | 57283 | 4.43 |
| 12:51 ET | 3488 | 4.425 |
| 12:53 ET | 5696 | 4.415 |
| 12:55 ET | 3386 | 4.435 |
| 12:57 ET | 1608 | 4.45 |
| 01:00 ET | 1313 | 4.445 |
| 01:02 ET | 1681 | 4.435 |
| 01:04 ET | 526 | 4.435 |
| 01:06 ET | 1816 | 4.435 |
| 01:08 ET | 2455 | 4.425 |
| 01:09 ET | 12619 | 4.425 |
| 01:11 ET | 2529 | 4.415 |
| 01:13 ET | 2578 | 4.42 |
| 01:15 ET | 8221 | 4.42 |
| 01:18 ET | 500 | 4.415 |
| 01:20 ET | 508 | 4.415 |
| 01:22 ET | 770 | 4.415 |
| 01:24 ET | 51635 | 4.43 |
| 01:26 ET | 252 | 4.425 |
| 01:27 ET | 7189 | 4.435 |
| 01:29 ET | 2658 | 4.415 |
| 01:31 ET | 3287 | 4.435 |
| 01:33 ET | 1834 | 4.435 |
| 01:36 ET | 2211 | 4.43 |
| 01:38 ET | 2307 | 4.415 |
| 01:40 ET | 219848 | 4.445 |
| 01:42 ET | 6607 | 4.45 |
| 01:44 ET | 3775 | 4.46 |
| 01:45 ET | 3500 | 4.47 |
| 01:47 ET | 17167 | 4.46 |
| 01:49 ET | 1853 | 4.465 |
| 01:51 ET | 9467 | 4.465 |
| 01:54 ET | 6347 | 4.466 |
| 01:56 ET | 5247 | 4.48 |
| 01:58 ET | 2414 | 4.475 |
| 02:00 ET | 1627 | 4.49 |
| 02:02 ET | 736 | 4.485 |
| 02:03 ET | 4329 | 4.465 |
| 02:05 ET | 976 | 4.465 |
| 02:07 ET | 4474 | 4.445 |
| 02:09 ET | 1510 | 4.445 |
| 02:12 ET | 3056 | 4.435 |
| 02:14 ET | 2126 | 4.425 |
| 02:16 ET | 1208 | 4.425 |
| 02:18 ET | 1110 | 4.43 |
| 02:20 ET | 2684 | 4.435 |
| 02:21 ET | 1236 | 4.425 |
| 02:23 ET | 2672 | 4.43 |
| 02:25 ET | 8526 | 4.43 |
| 02:27 ET | 6100 | 4.445 |
| 02:30 ET | 1887 | 4.435 |
| 02:32 ET | 1780 | 4.43 |
| 02:34 ET | 5284 | 4.445 |
| 02:36 ET | 2051 | 4.435 |
| 02:38 ET | 282 | 4.43 |
| 02:39 ET | 2400 | 4.445 |
| 02:41 ET | 500 | 4.445 |
| 02:43 ET | 1548 | 4.445 |
| 02:45 ET | 2981 | 4.435 |
| 02:48 ET | 1000 | 4.435 |
| 02:50 ET | 7764 | 4.42 |
| 02:52 ET | 2787 | 4.43 |
| 02:54 ET | 2100 | 4.41 |
| 02:56 ET | 3055 | 4.425 |
| 02:57 ET | 1045 | 4.425 |
| 02:59 ET | 1809 | 4.415 |
| 03:01 ET | 1920 | 4.415 |
| 03:03 ET | 3870 | 4.41 |
| 03:06 ET | 2629 | 4.405 |
| 03:08 ET | 7758 | 4.43 |
| 03:10 ET | 3676 | 4.425 |
| 03:12 ET | 5467 | 4.43 |
| 03:14 ET | 2018 | 4.445 |
| 03:15 ET | 1216 | 4.445 |
| 03:17 ET | 2195 | 4.445 |
| 03:19 ET | 9103 | 4.45 |
| 03:21 ET | 1932 | 4.445 |
| 03:24 ET | 1856 | 4.445 |
| 03:26 ET | 5200 | 4.445 |
| 03:28 ET | 3703 | 4.45 |
| 03:30 ET | 10816 | 4.445 |
| 03:32 ET | 13690 | 4.435 |
| 03:33 ET | 1663 | 4.435 |
| 03:35 ET | 4443 | 4.43 |
| 03:37 ET | 4771 | 4.415 |
| 03:39 ET | 3311 | 4.405 |
| 03:42 ET | 5824 | 4.425 |
| 03:44 ET | 1396 | 4.42 |
| 03:46 ET | 19323 | 4.42 |
| 03:48 ET | 13439 | 4.405 |
| 03:50 ET | 3503 | 4.4 |
| 03:51 ET | 3478 | 4.4 |
| 03:53 ET | 6847 | 4.395 |
| 03:55 ET | 12286 | 4.405 |
| 03:57 ET | 13262 | 4.395 |
| 04:00 ET | 161696 | 4.37 |
Nov 11, 2024
DJ Adaptive Biotechnologies Is Maintained at Overweight by Piper Sandler, from 8:00AM ET on Monday Nov 11, 2024 by Dow Jones
8:00AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
*DJ Adaptive Biotechnologies 3Q Loss/Shr 22c >ADPT, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
4:05PM ET on Thursday Nov 07, 2024 by Dow JonesAdaptive Biotechnologies Reports Third Quarter 2024 Financial Results, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
4:05PM ET on Thursday Nov 07, 2024 by Dow JonesAdaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ(R) for Assessing Measurable Residual Disease in Mantle Cell Lymphoma, from 7:30AM ET on Thursday Nov 07, 2024 by Dow Jones
7:30AM ET on Thursday Nov 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Adaptive Biotechnologies Corp | 644.9M | -3.3x | --- |
Arcturus Therapeutics Holdings Inc | 462.4M | -7.3x | --- |
Entrada Therapeutics Inc | 675.4M | 11.3x | --- |
Sangamo Therapeutics Inc | 408.1M | -2.8x | --- |
Avid Bioservices Inc | 783.5M | -5.4x | --- |
Akebia Therapeutics Inc | 397.1M | -8.2x | --- |
Company Information
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its proprietary technologies to read the diverse genetic code of a patient’s immune system and understand precisely how the immune system detects and treats disease in that patient. It has business around two main areas: clinical assessment of minimal residual disease (MRD) in lymphoid malignancies and immune medicine (IM)-driven drug discovery and development. The MRD business focuses on the use of its highly sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. It comprises its clonoSEQ clinical diagnostic test, offered to clinicians, and its clonoSEQ assay, offered to biopharmaceutical partners, to advance drug development efforts (MRD Pharma).
Contact Information
- Headquarters
- 1165 Eastlake Ave ESEATTLE, WA, United States 98109
- Phone
- 206-659-0067
- Fax
- 206-659-0667
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Chad Robins
- President, Chief Operating Officer
- Julie Rubinstein
- Co-Founder, Chief Scientific Officer
- Harlan Robins
- Chief Financial Officer
- Kyle Piskel
- Chief People Officer
- Francis Lo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $644.9M |
|---|---|
Revenue (TTM) | $177.3M |
Shares Outstanding | 147.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.42 |
EPS | $-1.34 |
Book Value | $2.13 |
P/E Ratio | -3.3x |
Price/Sales (TTM) | 3.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -112.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
